Protective effect of fufanghuangqiduogan against acute liver injury in mice
- PMID: 15902742
- PMCID: PMC4305673
- DOI: 10.3748/wjg.v11.i19.2984
Protective effect of fufanghuangqiduogan against acute liver injury in mice
Abstract
Aim: To study the effects and possible mechanisms of fufanghuangqiduogan (FFHQ) in mice with acute liver injury (ALI).
Methods: ALI was successfully induced by injecting carbon tetrachloride (CCl4) intraperitoneally and by tail vein injection of Bacillus Calmette Guerin (BCG) and lipopolysaccharide (LPS) in mice, respectively. Each of the two model groups was divided into normal group, model group, FFHQ (60, 120 and 240 mg/kg) treatment groups, and bifendate treatment group. At the end of the experiment, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), content of malondialdehyde (MDA), activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) in liver homogenate were measured by biochemical methods. The activities of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) were determined by radio-immunoassay. Hepatic tissue sections were stained with hematoxylin and eosin and examined under a light microscope.
Results: In the two models of ALI, FFHQ (60, 120, 240 mg/kg) was found to significantly decrease the serum transaminase (ALT, AST) activities. Meanwhile, FFHQ decreased MDA contents and upregulated the lower SOD and GSH-px levels in liver homogenate. Furthermore, in immunologic liver injury model, FFHQ decreased levels of TNF-alpha and IL-1 in serum. Histologic examination showed that FFHQ could attenuate the area and extent of necrosis, reduce the immigration of inflammatory cells.
Conclusion: FFHQ had protective effect on liver injury induced by either CCl4 or BCG+LPS in mice, and its mechanisms were related to free radical scavenging, increasing SOD and GSH-px activities and inhibiting the production of proinflammatory mediators.
Figures


References
-
- Dai LM, Chen XG, Xu SY. Protective effects of total glucosides of paeoney on experimental hepatitis. Zhongguo Yaolixue Tongbao. 1993;9:449–453.
-
- Shen WM, Wang CB, Wang DQ, Tian YP, Yan GT, Hao XH. The protective effects of TFA on reperfusion induced hepatic injury in hemorrhagic shock. Zhongguo Yaolixue Tongbao. 1997;13:532–534.
-
- Singh AK, Mani H, Seth P, Gaddipati JP, Kumari R, Banuadha KK, Sharma SC, Kulshreshtha DK, Maheshwari RK. Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol. 2000;395:229–239. - PubMed
-
- McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001;7:70–86, 88-90. - PubMed
-
- Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000;81:668–678. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical